MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

STERIS PLC

Închisă

SectorSănătate

221.06 -2.98

Rezumat

Modificarea prețului

24h

Curent

Minim

220.47

Maxim

226.95

Indicatori cheie

By Trading Economics

Venit

16M

173M

Vânzări

42M

1.4B

P/E

Medie Sector

36.498

63.778

EPS

2.32

Randament dividend

1.01

Marjă de profit

12.643

Angajați

18,000

EBITDA

-85M

245M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+16.45% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.01%

2.39%

Următoarele câștiguri

7 mai 2025

Data viitoare de dividende

25 iun. 2025

Următoarea dată ex-dividende

11 iun. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

22B

Deschiderea anterioară

224.04

Închiderea anterioară

221.06

Sentimentul știrilor

By Acuity

26%

74%

73 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

STERIS PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 feb. 2025, 21:35 UTC

Câștiguri

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5 feb. 2025, 21:34 UTC

Câștiguri

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5 feb. 2025, 21:34 UTC

Câștiguri

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5 feb. 2025, 21:33 UTC

Câștiguri

Steris 3Q EPS $1.75 >STE

5 feb. 2025, 21:30 UTC

Câștiguri

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5 feb. 2025, 21:30 UTC

Câștiguri

Steris 3Q Rev $1.4B >STE

5 feb. 2025, 21:30 UTC

Câștiguri

Steris 3Q Adj EPS $2.32 >STE

6 nov. 2024, 21:41 UTC

Câștiguri

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6 nov. 2024, 21:40 UTC

Câștiguri

Steris 2Q EPS $1.51 >STE

6 nov. 2024, 21:30 UTC

Câștiguri

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6 nov. 2024, 21:30 UTC

Câștiguri

Steris 2Q Adj EPS $2.14 >STE

6 nov. 2024, 21:30 UTC

Câștiguri

Steris 2Q Rev $1.3B >STE

6 aug. 2024, 20:36 UTC

Câștiguri

Steris 1Q Adj EPS $2.03 >STE

6 aug. 2024, 20:30 UTC

Câștiguri

Steris 1Q Net $139.9M >STE

6 aug. 2024, 20:30 UTC

Câștiguri

Steris 1Q EPS $1.41 >STE

6 aug. 2024, 20:30 UTC

Câștiguri

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

3 iun. 2024, 11:03 UTC

Achiziții, Fuziuni, Preluări

PEAK ROCK Cap Affil COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION of HUFRIEDYGROUP

31 mai 2024, 20:47 UTC

Achiziții, Fuziuni, Preluări

Steris Completes $787.5M Sale of Dental Segment to Peak Rock Capital

8 mai 2024, 20:40 UTC

Câștiguri

Steris Sees FY25 Adj EPS $9.05-Adj EPS $9.25 >STE

8 mai 2024, 20:39 UTC

Câștiguri

Steris: Plan Includes Restructuring of the Healthcare Surgical Business in Europe >STE

8 mai 2024, 20:39 UTC

Câștiguri

Steris Announcing a Targeted Restructuring Plan >STE

8 mai 2024, 20:39 UTC

Câștiguri

Steris 4Q EPS $3.81 >STE

8 mai 2024, 20:30 UTC

Câștiguri

Steris 4Q Adj EPS $2.58 >STE

11 apr. 2024, 11:01 UTC

Achiziții, Fuziuni, Preluări

Steris Expects Resulting Benefit of Reduction in Interest Expense to Be About $0.35 Per Shr >STE

11 apr. 2024, 11:00 UTC

Achiziții, Fuziuni, Preluări

Steris: Transaction Is Anticipated to Close in 1Q of Fiscal Yr 2025 >STE

11 apr. 2024, 10:59 UTC

Achiziții, Fuziuni, Preluări

Steris: Transaction Terms Include Opportunity to Receive Additional Earnout of Up to $12.5M >STE

11 apr. 2024, 10:59 UTC

Achiziții, Fuziuni, Preluări

Steris: Transaction Is Structured as Equity Sale >STE

11 apr. 2024, 10:58 UTC

Achiziții, Fuziuni, Preluări

Steris Enters Agreement to Divest Dental Segment to Peak Rock Cap for $787.5M >STE

11 apr. 2024, 10:58 UTC

Achiziții, Fuziuni, Preluări

STERIS to Sell Dental Segment to an Affiliate of Peak Rock Capital for $787.5M

Comparație

Modificare preț

STERIS PLC Așteptări

Obiectiv de preț

By TipRanks

16.45% sus

Prognoză pe 12 luni

Medie 265 USD  16.45%

Maxim 265 USD

Minim 265 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruSTERIS PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

3 ratings

2

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

222.25 / 228.22Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Weak Bullish Evidence

Sentiment

By Acuity

73 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.